Advertisement
Advertisement
U.S. markets open in 1 hour 31 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Stryker Corporation (SYK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
224.57+1.45 (+0.65%)
At close: 04:03PM EDT
222.07 -2.50 (-1.11%)
Pre-Market: 07:45AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close223.12
Open221.98
Bid221.64 x 900
Ask225.39 x 800
Day's Range221.53 - 225.45
52 Week Range188.84 - 281.16
Volume1,457,234
Avg. Volume1,454,796
Market Cap84.96B
Beta (5Y Monthly)1.03
PE Ratio (TTM)41.36
EPS (TTM)5.43
Earnings DateOct 26, 2022 - Oct 31, 2022
Forward Dividend & Yield2.78 (1.24%)
Ex-Dividend DateSep 29, 2022
1y Target Est240.29
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-18% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SYK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Stryker Corporation
    Analyst Report: Stryker CorporationStryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States.
    Rating
    Fair Value
    Economic Moat
    20 days agoMorningstar
View more
Advertisement
Advertisement